Chemotherapy for endocrine resistant cancer of the prostate.
Eisenberger
M A
MA
Department of Medicine, University of Maryland, Baltimore.
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D004341:Drug Evaluation; D006801:Humans; D008297:Male; D011446:Prospective Studies; D011471:Prostatic Neoplasms / Q000188:drug therapy*
D000970:Antineoplastic Agents